Literature DB >> 35681014

Ptpn1 deletion protects oval cells against lipoapoptosis by favoring lipid droplet formation and dynamics.

Ruben Grillo-Risco1, Laura Pereira2,3, M Carmen Soler-Vázquez4, Inés Barahona5,2, Patricia Rada5,2, Silvia Calero-Pérez5,2, Laura María LaIglesia6, María J Moreno-Aliaga6,7,8, Laura Herrero4,7, Dolors Serra4,7, Carmelo García-Monzon9,10, Águeda González-Rodriguez2,9,5, Jesús Balsinde2,3, Francisco García-García1, M Pilar Valdecantos11,12, Ángela M Valverde13,14.   

Abstract

Activation of oval cells (OCs) has been related to hepatocyte injury during chronic liver diseases including non-alcoholic fatty liver disease (NAFLD). However, OCs plasticity can be affected under pathological environments. We previously found protection against hepatocyte cell death by inhibiting protein tyrosine phosphatase 1B (PTP1B). Herein, we investigated the molecular and cellular processes involved in the lipotoxic susceptibility in OCs expressing or not PTP1B. Palmitic acid (PA) induced apoptotic cell death in wild-type (Ptpn1+/+) OCs in parallel to oxidative stress and impaired autophagy. This lipotoxic effect was attenuated in OCs lacking Ptpn1 that showed upregulated antioxidant defences, increased unfolded protein response (UPR) signaling, higher endoplasmic reticulum (ER) content and elevated stearoyl CoA desaturase (Scd1) expression and activity. These effects in Ptpn1-/- OCs concurred with an active autophagy, higher mitochondrial efficiency and a molecular signature of starvation, favoring lipid droplet (LD) formation and dynamics. Autophagy blockade in Ptpn1-/- OCs reduced Scd1 expression, mitochondrial fitness, LD formation and restored lipoapoptosis, an effect also recapitulated by Scd1 silencing. PTP1B immunostaining was detected in OCs from mouse liver and, importantly, LDs were found in OCs from Ptpn1-/- mice with NAFLD. In conclusion, we demonstrated that Ptpn1 deficiency restrains lipoapoptosis in OCs through a metabolic rewiring towards a "starvation-like" fate, favoring autophagy, mitochondrial fitness and LD formation. Dynamic LD-lysosomal interations likely ensure lipid recycling and, overall, these adaptations protect against lipotoxicity. The identification of LDs in OCs from Ptpn1-/- mice with NAFLD opens therapeutic perspectives to ensure OC viability and plasticity under lipotoxic liver damage.
© 2022. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Year:  2022        PMID: 35681014     DOI: 10.1038/s41418-022-01023-x

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  64 in total

1.  Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.

Authors:  Yuko Akazawa; Sophie Cazanave; Justin L Mott; Nafisa Elmi; Steven F Bronk; Shigeru Kohno; Michael R Charlton; Gregory J Gores
Journal:  J Hepatol       Date:  2010-02-13       Impact factor: 25.083

2.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1.

Authors:  M Miyazaki; Y C Kim; M P Gray-Keller; A D Attie; J M Ntambi
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

4.  Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease.

Authors:  Valerio Nobili; Guido Carpino; Anna Alisi; Antonio Franchitto; Gianfranco Alpini; Rita De Vito; Paolo Onori; Domenico Alvaro; Eugenio Gaudio
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

5.  Protein tyrosine phosphatase 1B interacts with the activated insulin receptor.

Authors:  B L Seely; P A Staubs; D R Reichart; P Berhanu; K L Milarski; A R Saltiel; J Kusari; J M Olefsky
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

6.  Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

Authors:  Ariel E Feldstein; Ali Canbay; Paul Angulo; Makiko Taniai; Lawrence J Burgart; Keith D Lindor; Gregory J Gores
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

8.  Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

Authors:  Michelle M Richardson; Julie R Jonsson; Elizabeth E Powell; Elizabeth M Brunt; Brent A Neuschwander-Tetri; Prithi S Bhathal; John B Dixon; Martin D Weltman; Herbert Tilg; Alexander R Moschen; David M Purdie; Anthony J Demetris; Andrew D Clouston
Journal:  Gastroenterology       Date:  2007-05-16       Impact factor: 22.682

Review 9.  Dynamics and functions of lipid droplets.

Authors:  James A Olzmann; Pedro Carvalho
Journal:  Nat Rev Mol Cell Biol       Date:  2019-03       Impact factor: 94.444

10.  Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.

Authors:  A González-Rodríguez; R Mayoral; N Agra; M P Valdecantos; V Pardo; M E Miquilena-Colina; J Vargas-Castrillón; O Lo Iacono; M Corazzari; G M Fimia; M Piacentini; J Muntané; L Boscá; C García-Monzón; P Martín-Sanz; Á M Valverde
Journal:  Cell Death Dis       Date:  2014-04-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.